Ciliatech

Medtech company developing a new class of #glaucoma implant, CID (Cilio-Scleral Inter-positioning Device) - the first to leave the anterior chamber intact

[Ciliatech @cilia_tech]

📢 We are pleased to announce the design of our second-generation CID (Cilioscleral Interpositioning Device)

☑ New design makes cilioscleral surgical procedure, which leaves the anterior chamber of the eye untouched, less invasive and easier to perform

https://t.co/S9EePlZDKk

[Andrew Lloyd ALA @ALA_Group]

[ALA Client News] @cilia_tech’s glaucoma implant CID receives favorable opinion on treating both open and narrow angle forms of disease

https://t.co/LyfihfHPQL

#ophthalmology #medtech #glaucoma #ICGS2024

[Glaucoma Physician @GlaucomaPhys]

Cilioscleral Interposition Device for Intraocular Pressure Lowering: A new device grows the #glaucoma arsenal while potentially preventing endothelial cell loss and inflammation. By Philippe Sourdille, MD https://t.co/DOxRwpZ5Bn

[MedTech Strategist | MedTech's Most Trusted Source @MedTechStrat]

.@BDandCo's CTO Beth McCombs discusses her approach to driving innovation at the global #MedTech giant; with Larimar buy, @JNJMedTech executes on its goal of upping its mix of high-growth products. Plus profiles of @ArsenalMedical and @cilia_tech: https://t.co/DuPAt3rnNH

[Ciliatech @cilia_tech]

📰Have you read how our cilioscleral interposition approach fits in with the current #glaucoma surgical landscape?

Learn more about our innovative surgical technique below👇
https://t.co/SycmvUdPqy

#ophthalmology #eyecare #medtech #surgery

[Ciliatech @cilia_tech]

Learn more about the benefits of CID including no endothelial cell loss on our website ➡ https://t.co/v9WYUS8lwW
#PACG #implant #medtech #innovation #ophthalmology

[Ciliatech @cilia_tech]

We recently updated the design of our Cilio-Scleral Inter-positioning Device (CID) implant to be used in the treatment of both open-angle and narrow-angle #glaucoma 👁
📺 ⬇ Watch the video below to learn about the updates and how it's inserted using the cilioscleral technique

[Ciliatech @cilia_tech]

🗞@GlaucomaPhys is talking about the results of our SAFARI III study, which show the benefits of our CID implant for both primary open-angle glaucoma (#POAG) and primary angle-closure #glaucoma (#PACG) patients

Read more on page 6👇 https://t.co/sC54FtDodr…

#Ophthalmology

[Ciliatech @cilia_tech]

#PACG represents a significant cause of blindness, affecting more than 17M people globally 🌎

Learn more about our unique approach to treating PACG which lowers IOP represents a new, efficient, and safe surgical option to reduce intraocular pressure!

https://t.co/EfBwzC0ueW

[Ciliatech @cilia_tech]

🗞 Our CEO @Olivier Benoit spoke with @MedTech Strategist to discuss all things Ciliatech, from our CID device, which can be used to treat narrow angle glaucoma, to our pioneering cilioscleral surgical technique.

https://t.co/zmkxa0vjQ8
#ophthalmology #medtech #glaucoma #MIGS

[Eyewire+ @eyewireplus]

.@cilia_tech announced the release of a new design of its #CID (cilioscleral interpositioning device) following the filing of additional patents strengthening its IP (intellectual property). https://t.co/nkg4C4brFE

[Ciliatech @cilia_tech]

Watch the new CID implant in action in the animation below👇

#medtech #ophthalmology #implant #glaucoma #patents

[Ciliatech @cilia_tech]

📢 We are pleased to announce the design of our second-generation CID (Cilioscleral Interpositioning Device)

☑ New design makes cilioscleral surgical procedure, which leaves the anterior chamber of the eye untouched, less invasive and easier to perform

https://t.co/S9EePlZDKk

[Ciliatech @cilia_tech]

With innovation comes concerns, our CID implant requires a minimally invasive procedure to be inserted.

Dr Voskanyan, head of glaucoma department at S.V. Malayan’s Eye Center explains the benefits of the surgery🙌

More about CID👇
https://t.co/v9WYUS8Tmu

[Ciliatech @cilia_tech]

☑️ Advantages of #CIDsurgery

Iatrogenic risk of corneal endothelial cells loss simply does not exist, and no bleb is created.

Learn more about the cilioscleral technique👇 https://t.co/Ufc3ztZ1xk

[Ciliatech @cilia_tech]

Learn more about CID and the cilioscleral technique on our website 👇

https://t.co/G878gjHhmJ

#glaucomasurgery #medicaldevices #surgery #innovation #ophthalmology

[Ciliatech @cilia_tech]

📈We have been featured in @expertmresearch's report on the Global #Glaucoma Surgery Devices Market

The report spotlights our CID implant as one of the new methods to help reduce IOP without entering the eye's anterior chamber 👁

https://t.co/EPe1iYnsyL

[Ciliatech @cilia_tech]

#PACG represents a significant cause of blindness, affecting more than 17M people globally 🌎

Learn more about our unique approach to treating PACG which lowers IOP represents a new, efficient, and safe surgical option to reduce intraocular pressure!👇

https://t.co/EfBwzC124u

[Ciliatech @cilia_tech]

The device’s two faces and edges are designed with grooves and corrugations to maximise the outflow from the anterior chamber and its circulation to the choroid and the sclera-conjunctival vessels

Learn about how CID works👇 https://t.co/v9WYUS8lwW
#medtech #ophthalmology

[Ciliatech @cilia_tech]

Today we are spotlighting the design elements of our #glaucoma implant, CID👁️

CID is a non-resorbable implant which remains in place for the patient’s lifetime

[Ciliatech @cilia_tech]

It is a one-piece of 26% hydrophilic acrylic, a raw material widely used in the manufacturing of intra-ocular lenses, which ensures long-term biocompatibility🤝

It consists of a specifically designed 6mm large, 4 mm wide, and 200µm thick plate*

*Patent pending